Depression Center Task Force News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Depression Center Task Force. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Depression Center Task Force Today - Breaking & Trending Today

MIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2

Published: November 20, 2023

– New Chemical Entity Aims to Provide New Treatments for Refractory Depression and Depression with Suicidal Thoughts – – Ketamir-2 Is Being Developed As a Take Home Alternative to The...

Source: marketscreener.com

Related Topics:

Adam KaplinErez AminovJohns Hopkins EsketamineJohns HopkinsDrug AdministrationPharmaceuticals IncJanssen Pharmaceuticals IncUs Drug Enforcement AdministrationNew Chemical Entity AimsProvide New TreatmentsRefractory DepressionSuicidal ThoughtsTake Home AlternativeRevolutionary Drug SpravatoWhich MustDosed Under Medical ObservationEnforcement AdministrationControlled Substances ActChief Scientific OfficerJohns Hopkins MedicinePrincipal InvestigatorJohns Hopkins Esketamine ClinicNational NetworkDepression Center Task ForceChief Executive Officer